Canada vs New Zealand: Proportion of isolates with decreased susceptibility or resistance
Canada
0.5445
in 2018
New Zealand
0.4386
in 2017
Canada rank
20th
New Zealand rank
22nd
Proportion of isolates with decreased susceptibility or resistance over time
- Canada
- New Zealand
How they compare
Canada currently reports 0.5445 against 0.4386 in New Zealand, a difference of 0.1059.
That makes Canada's figure about 1.2 times New Zealand's.
Across all 9 years both countries report, Canada has been ahead every year.
Canada ranks 20th and New Zealand ranks 22nd of 51 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 3.09 | 0 | 3.09 | Canada |
| 2010s | 3.97 | 0.3595 | 3.61 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Canada or New Zealand?
- Canada, at 0.5445 against 0.4386 in New Zealand as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Canada and New Zealand?
- 0.1059, with Canada ahead.
- How many years of comparable data are there for Canada and New Zealand?
- 9 years are reported by both, from 2009 to 2017.
- How do Canada and New Zealand rank globally for proportion of isolates with decreased susceptibility or resistance?
- Canada ranks 20th and New Zealand ranks 22nd of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.